drugset / Trial / NCT04199585

Safety and Tolerability of Lu AF95245 in Healthy Young Men

NCT04199585 ↗

Phase 1 Terminated 18 enrolled H. Lundbeck A/S
RandomizedSequentialDouble-blindTreatment

Summary

The purpose of this study is to investigate the safety and tolerability of Lu AF95245 and what the body does to Lu AF95245 after swallowing single doses of the drug

Timeline

Start
2019-12-10
Primary completion
2020-02-16
Completion
2020-02-19

Outcome

Outcome not reported

Stopped: “new safety data from another study”

Drugs

EvaluationDrugModalityDoseRoute
Subject Lu AF95245 Unknown — Oral

Indications

No indication recorded.